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SUMMARY. Informing patients about rational drug use is necessary when therapies involve medications
with adverse effects that can compromise treatment adherence. The aim of the present study was to evalu-
ate the importance of the pharmaceutical professional in home visits. The study focused on a Palliative
Care Unit Home Care Program, which orients patients and/or caregivers about home drug use. Paid phar-
maceutical visits were conducted among 47 patients. During the first visit, incorrect medication prescrip-
tions were observed for 21 patients (61.7 %); after subsequent visits, the average rate of correct prescrip-
tion was 75 %. The present study observed a need for a professional who is exclusively dedicated to thera-
peutic drug monitoring during in-home pharmaceutical visits. 
